Withaferin A decreases glycolytic reprogramming in breast cancerAsifa Khan(University of Massachusetts Chan Medical School), Mohammad Askandar Iqbal(Gulf Medical University)Scientific ReportsOctober 4, 202410.1038/s41598-024-72221-5Cited by 12SaveCiteExport RISWatch citationsRelated PapersCurcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition|Scientific Reports|2018|147Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer|Molecular Oncology|2021|52